Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Transplant Proc ; 53(1): 221-227, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-32650991

RESUMO

BACKGROUND: Mammalian target of rapamycin (mTOR) inhibitors following liver transplantation (LT) are used to minimize calcineurin inhibitor (CNI)-related nephrotoxicity. Data about metabolic effects of mTOR inhibitors are still limited. AIM: This study aims to determine the renal and metabolic effects of different mTOR inhibitor-based protocols in real-life LT patients. METHODS: This is a retrospective cohort study of patients treated with mTOR inhibitors after LT. Demographics, treatment protocols, glomerular filtration rate (GFR), and metabolic parameters were collected over a period of 4 years. Initiation of blood pressure (BP), diabetes mellitus, and lipid medications was also noted. RESULTS: Fifty-two LT recipients received mTOR inhibitors. GFR improved significantly (by 1.96 mL/min/year), with greater improvement in patients with baseline renal dysfunction (+13.3 mL/min vs +4.5 mL/min at 3 years). Conversion to an mTOR inhibitor during the first post-transplant year resulted in a more durable improvement in GFR (for 4 years vs only 1 year for later conversion).No significant weight gain or new-onset diabetes mellitus was observed. However, there was some increase in total cholesterol (+7 mg/dL) and blood pressure (+2 mm Hg during the third year and +8 mm Hg in the fourth years), followed by initiation of lipid-lowering and BP medications in 25% and 13% of patients, respectively. CONCLUSIONS: Treatment with an mTOR inhibitor following LT resulted in improved kidney functions without significant negative metabolic effects such as weight gain or new-onset diabetes mellitus. This makes mTOR inhibitors a valuable immunosuppressive option in the face of the growing incidence of nonalcoholic steatohepatitis as a leading cause for LT.


Assuntos
Everolimo/uso terapêutico , Imunossupressores/uso terapêutico , Transplante de Fígado , Complicações Pós-Operatórias/prevenção & controle , Sirolimo/uso terapêutico , Idoso , Inibidores de Calcineurina/efeitos adversos , Estudos de Coortes , Feminino , Humanos , Rim/efeitos dos fármacos , Nefropatias/epidemiologia , Nefropatias/etiologia , Nefropatias/prevenção & controle , Transplante de Fígado/efeitos adversos , Masculino , Síndrome Metabólica/epidemiologia , Síndrome Metabólica/etiologia , Pessoa de Meia-Idade , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etiologia , Estudos Retrospectivos
3.
Am J Med ; 85(6): 839-44, 1988 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-3057903

RESUMO

The range of neuro-ophthalmologic signs in temporal arteritis is broad and includes diverse presentations of ischemic optic neuropathy, retinal infarction, transient ischemic phenomena, ophthalmoparesis, pupillary autonomic and anterior ocular segment dysfunction, cortical blindness and associated post-chiasmal field defects, and complex visual hallucinations. Neurovascular compromise can follow arteritic lesions at multiple neuroanatomic sites, and reflects different pathogenetic mechanisms and displays distinctive clinical features. A variety of temporal clinical profiles and differential responses to corticosteroids occur. This article reviews the broad range of neuroanatomic pathways affected by diverse and potentially interactive etiologic factors in this systemic arteritis.


Assuntos
Doenças do Sistema Nervoso Autônomo/etiologia , Arterite de Células Gigantes/complicações , Oftalmoplegia/etiologia , Transtornos da Visão/etiologia , Humanos
4.
Ann Ophthalmol ; 20(10): 400-2, 1988 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-3207315

RESUMO

The neuro-ophthalmologic spectrum of temporal arteritis (TA) is broad and includes such diverse presentations as ischemic optic neuropathy, retinal infarction, anterior ocular segment dysfunction, ophthalmoparesis, and cortical blindness. A common clinical dictum suggests that third nerve palsies are associated with pupillary sparing in this systemic arteritis. We present a biopsy-proven case of TA with parasympathetic pupillary involvement and ophthalmoparesis. Relative light-near dissociation and differential clinical response to adrenocorticosteroids occurred. Previous pathologic studies have suggested that clinically apparent parasympathetic pupillary dysfunction could follow arteritic lesions at several neuroanatomic sites and may, therefore, reflect different pathogenetic mechanisms and display distinctive clinical features. Our case effectively broadens the clinicopathologic locus of neuro-ophthalmologic expression in TA.


Assuntos
Arterite de Células Gigantes/fisiopatologia , Sistema Nervoso Parassimpático/fisiopatologia , Pupila , Idoso , Idoso de 80 Anos ou mais , Feminino , Arterite de Células Gigantes/complicações , Humanos , Oftalmoplegia/etiologia , Oftalmoplegia/fisiopatologia , Visão Ocular
5.
Ann Neurol ; 23(4): 413-5, 1988 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3382180

RESUMO

We report on a 12-year-old girl with a severe subacute to chronic bifrontal leukoencephalopathy. By clinical, biochemical, radiological, and neuropathological criteria, a diagnosis of inflammatory myelinoclastic diffuse sclerosis was reached. This is the third fully documented case.


Assuntos
Esclerose Cerebral Difusa de Schilder/patologia , Criança , Esclerose Cerebral Difusa de Schilder/diagnóstico por imagem , Feminino , Humanos , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA